Stock Scorecard



Stock Summary for TRACON Pharmaceuticals Inc (TCON) - $0.43 as of 3/29/2024 8:10:52 AM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TCON

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TCON

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TCON

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TCON

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TCON

StockNews.com Initiates Coverage on TRACON Pharmaceuticals ( NASDAQ:TCON ) 3/23/2024 6:14:00 AM
I-Mab Reports Full Year 2023 Financial Results and Business Update 3/14/2024 9:00:00 PM
StockNews.com Begins Coverage on TRACON Pharmaceuticals ( NASDAQ:TCON ) 3/14/2024 6:26:00 AM
StockNews.com Begins Coverage on TRACON Pharmaceuticals ( NASDAQ:TCON ) 3/14/2024 6:24:00 AM
TRACON Pharmaceuticals ( NASDAQ:TCON ) Earns Hold Rating from Analysts at StockNews.com 3/6/2024 7:12:00 AM
TRACON Pharmaceuticals ( NASDAQ:TCON ) Coverage Initiated by Analysts at StockNews.com 2/27/2024 7:22:00 AM
StockNews.com Initiates Coverage on TRACON Pharmaceuticals ( NASDAQ:TCON ) 2/27/2024 7:20:00 AM
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and ... - PR Newswire 1/26/2024 1:15:00 AM
TRACON Pharmaceuticals ( NASDAQ:TCON ) Research Coverage Started at StockNews.com 1/2/2024 6:28:00 AM
TRACON Pharmaceuticals ( NASDAQ:TCON ) Coverage Initiated at StockNews.com 12/25/2023 6:40:00 AM

Financial Details for TCON

Company Overview

Ticker TCON
Company Name TRACON Pharmaceuticals Inc
Country USA
Description TRACON Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for cancer and age-related macular degeneration and fibrotic diseases in the United States. The company is headquartered in San Diego, California.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 12/31/2023
Next Earnings Date 5/8/2024

Stock Price History

Last Day Price 0.43
Last Day Price Updated 3/29/2024 8:10:52 AM EST
Last Day Volume 3,133,932
Average Daily Volume 5,069,800
52-Week High 2.14
52-Week Low 0.13
Last Price to 52 Week Low 230.77%

Valuation Measures

Trailing PE N/A
Industry PE 67.80
Sector PE 62.25
5-Year Average PE -1.46
Free Cash Flow Ratio 2.26
Industry Free Cash Flow Ratio 17.19
Sector Free Cash Flow Ratio 31.21
Current Ratio Most Recent Quarter 0.89
Total Cash Per Share 0.19
Book Value Per Share Most Recent Quarter -0.02
Price to Book Ratio 11.83
Industry Price to Book Ratio 7.28
Sector Price to Book Ratio 21.72
Price to Sales Ratio Twelve Trailing Months 1.68
Industry Price to Sales Ratio Twelve Trailing Months 32.57
Sector Price to Sales Ratio Twelve Trailing Months 8.86

Share Statistics

Total Shares Outstanding 45,504,500
Market Capitalization 19,566,935
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 87.68%
Reported EPS 12 Trailing Months -0.11
Reported EPS Past Year 0.16
Reported EPS Prior Year -1.40
Net Income Twelve Trailing Months -3,588,000
Net Income Past Year -3,588,000
Net Income Prior Year -29,135,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 32.05%

Balance Sheet

Total Cash Most Recent Quarter 8,600,000
Total Cash Past Year 8,600,000
Total Cash Prior Year 17,500,000
Net Cash Position Most Recent Quarter 8,600,000
Net Cash Position Past Year -1,207,000
Long Term Debt Past Year 9,807,000
Long Term Debt Prior Year 9,807,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year -0.09
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year -809,000
Total Stockholder Equity Prior Year -7,151,000
Total Stockholder Equity Most Recent Quarter -809,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.06
MACD Signal 0.06
20-Day Bollinger Lower Band 0.05
20-Day Bollinger Middle Band 0.22
20-Day Bollinger Upper Band 0.40
Beta 0.79
RSI 57.61
50-Day SMA 0.36
200-Day SMA 3.00

System

Modified 3/29/2024 8:10:55 AM EST